WuXi Biologics Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- 108 Meiliang Road, Mashan, Binhu District, Wuxi, Jiangsu 214092, China (CHN)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 3010606982 · DUNS 421298354
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2021-04-02
- VAIDrug Quality Assurance2019-04-16
Drugs this plant is listed as making
4 distinct drugs across 5 products name this site in their FDA label.
- nipocalimab-aahuJanssen Biotech, Inc.
- pemivibartInvivyd, Inc
- vilobelimabInflaRx GmbH
- zanidatamab-hriiJazz Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.